Reduction of liver macrophage transduction by pseudotyping lentiviral vectors with a fusion envelope from Autographa californica GP64 and Sendai virus F2 domain

[1]  J. Seppen,et al.  Preferential gene transfer of lentiviral vectors to liver-derived cells, using a hepatitis B peptide displayed on GP64. , 2007, Human gene therapy.

[2]  B. Davidson,et al.  Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer. , 2005, Blood.

[3]  T. Friedmann,et al.  Baculovirus GP64-pseudotyped HIV-based lentivirus vectors are stabilized against complement inactivation by codisplay of decay accelerating factor (DAF) or of a GP64-DAF fusion protein. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  K. Cornetta,et al.  Lentiviral vectors pseudotyped with glycoproteins from Ross River and vesicular stomatitis viruses: variable transduction related to cell type and culture conditions. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  Varpu Marjomäki,et al.  Enhanced gene delivery by avidin-displaying baculovirus. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  G. Veres,et al.  Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro , 2004, Gene Therapy.

[7]  F. Cosset,et al.  Surface‐engineering of lentiviral vectors , 2004, The journal of gene medicine.

[8]  S. Yoshida,et al.  Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infection. , 2003, Virology.

[9]  I. Martins,et al.  In Vivo Gene Transfer Using a Nonprimate Lentiviral Vector Pseudotyped with Ross River Virus Glycoproteins , 2002, Journal of Virology.

[10]  G. Kobinger,et al.  Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  P. Morel,et al.  Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  J. Yee,et al.  Preferential transduction of human hepatocytes with lentiviral vectors pseudotyped by Sendai virus F protein. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[13]  J. Seppen,et al.  Lentiviral vectors for efficient transduction of isolated primary quiescent hepatocytes. , 2002, Journal of hepatology.

[14]  L. Naldini,et al.  Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. , 2002, Human gene therapy.

[15]  D. Lavillette,et al.  Retargeting gene delivery using surface-engineered retroviral vector particles. , 2001, Current opinion in biotechnology.

[16]  I. Verma,et al.  Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[17]  K. Takkinen,et al.  Baculoviral display of functional scFv and synthetic IgG-binding domains. , 2000, Biochemical and biophysical research communications.

[18]  F. Cosset,et al.  Modifying the host range properties of retroviral vectors , 1999, The journal of gene medicine.

[19]  W. Anderson,et al.  Identification of the block in targeted retroviral-mediated gene transfer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  H. Rossmann,et al.  Pseudotype Formation of Moloney Murine Leukemia Virus with Sendai Virus Glycoprotein F , 1998, Journal of Virology.

[21]  K. Keinänen,et al.  Baculoviral display of the green fluorescent protein and rubella virus envelope proteins. , 1997, Biochemical and biophysical research communications.

[22]  P. Schlag,et al.  Gene transfer into hepatocytes and human liver tissue by baculovirus vectors. , 1996, Human gene therapy.

[23]  F. Boyce,et al.  Baculovirus-mediated gene transfer into mammalian cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Ian M. Jones,et al.  Eukaryotic Virus Display: Engineering the Major Surface Glycoprotein of the Autographa californica Nuclear Polyhedrosis Virus (AcNPV) for the Presentation of Foreign Proteins on the Virus Surface , 1995, Bio/Technology.

[25]  Yamamura Ken-ichi,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .

[26]  H. Niwa,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.

[27]  A. Schwartz,et al.  An alternative route of infection for viruses: entry by means of the asialoglycoprotein receptor of a Sendai virus mutant lacking its attachment protein. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Scheid,et al.  Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus. , 1974, Virology.

[29]  M. Ohuchi,et al.  Trypsin Action on the Growth of Sendai Virus in Tissue Culture Cells III. Structural Difference of Sendai Viruses Grown in Eggs and Tissue Culture Cells , 1973, Journal of virology.

[30]  M. Homma.  Trypsin Action on the Growth of Sendai Virus in Tissue Culture Cells , 1971, Microbiology and immunology.

[31]  M. Homma.  Trypsin action on the growth of Sendai virus in tissue culture cells. I. Restoration of the infectivity for L cells by direct action of tyrpsin on L cell-borne Sendai virus. , 1971, Journal of virology.

[32]  J. Seppen,et al.  Kupffer cells and not liver sinusoidal endothelial cells prevent lentiviral transduction of hepatocytes. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[33]  J. Zimmerberg,et al.  Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64. , 2003, Human gene therapy.

[34]  I. Verma,et al.  Opportunities for the use of lentiviral vectors in human gene therapy. , 2002, Current topics in microbiology and immunology.

[35]  L. Ailles,et al.  HIV-1-derived lentiviral vectors. , 2002, Current topics in microbiology and immunology.

[36]  D. Trono.  Lentiviral vectors: turning a deadly foe into a therapeutic agent , 2000, Gene Therapy.